Mosaic ImmunoEngineering (CPMV) Tax Provisions (2010 - 2025)

Mosaic ImmunoEngineering (CPMV) posted Tax Provisions of $2400.0 for Q2 2025, little changed on a QoQ basis from $2400.0 in Q4 2024.

Analysis

Mosaic ImmunoEngineering (CPMV) Tax Provisions (2010 - 2025) Analysis & Trends

Mosaic ImmunoEngineering has reported Tax Provisions for 16 years, with the latest figure at $2400.0 in Q2 2025.

On a quarterly basis, Tax Provisions changed N/A year-over-year to $2400.0 in Q2 2025; TTM through Mar 2026 was $2400.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2400.0, changed 0.0% from the prior year.
Tax Provisions was $2400.0 for Q2 2025 at Mosaic ImmunoEngineering, roughly flat from $2400.0 in the prior quarter.
The five-year high for Tax Provisions was $2400.0 in Q1 2021, with the low at $2400.0 in Q1 2021.
Average Tax Provisions over 5 years is $2400.0, with a median of $2400.0 recorded in 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Amgen	211.73 Bn	197.74 Bn	7.24 Bn	393.00 Mn
2	Gilead Sciences	180.92 Bn	177.74 Bn	6.22 Bn	242.00 Mn
3	Vertex Pharmaceuticals	132.16 Bn	124.30 Bn	2.84 Bn	292.00 Mn
4	Regeneron Pharmaceuticals	82.89 Bn	74.90 Bn	3.93 Bn	230.90 Mn
5	Argenx Se	61.41 Bn	56.23 Bn	1.37 Bn	-59.00 Mn
6	Moderna	53.99 Bn	48.85 Bn	52.00 Mn	15.00 Mn
7	Alnylam Pharmaceuticals	34.48 Bn	31.18 Bn	992.69 Mn	13.31 Mn
8	Biogen	31.15 Bn	29.86 Bn	1.96 Bn	34.90 Mn
9	Roivant Sciences	30.05 Bn	30.05 Bn	1.16 Mn	-3.96 Mn
10	Mosaic ImmunoEngineering	434,528.21	434,528.21	-	-

Historic Data

Download Data